Pfizer PFE Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $14.45B+5.4% | $17.56B-1.2% | $16.65B-5.9% | $14.65B+10.3% | $13.72B-7.8% | ||
| $3.55B+24.7% | $5.27B-10.8% | $4.17B-20.7% | $3.78B+14.5% | $2.85B-15.8% | ||
| $10.9B+0.3% | $12.29B+3.6% | $12.48B+0.3% | $10.88B+8.9% | $10.87B-5.5% | ||
| 75.4%-3.8pp | 70%+3.2pp | 74.9%+4.7pp | 74.2%-0.9pp | 79.3%+2.0pp | ||
| $2.96B-2.3% | $4.16B-2.6% | $3.19B-1.8% | $3.42B-8.1% | $3.03B-13.3% | ||
| $3.17B+13.8% | —— | $3.33B-29.3% | $3.04B+3,055% | $2.79B-18.6% | ||
| $461M+344% | -$2M+99.5% | -$216M-192% | $141M+205% | -$189M-165% | ||
| $2.69B-9.4% | —— | $3.54B-20.7% | $2.91B+6,998% | $2.97B-4.8% | ||
| 18.6%-3.0pp | —— | 21.3%-4.0pp | 19.9%+19.6pp | 21.6%+0.7pp | ||
| $0.47-9.6% | —— | $0.62-20.5% | $0.51+5,000% | $0.52-5.5% | ||
| $4.78B+8.6% | —— | $5B-22.8% | $4.67B+187% | $4.4B-26.0% | ||
| 33.1%+1.0pp | —— | 30%-6.6pp | 31.9%+19.6pp | 32.1%-7.9pp | ||
| $3.17B+13.8% | —— | $3.33B-29.3% | $3.04B+3,055% | $2.79B-33.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Pfizer's revenue?
- Pfizer (PFE) generated $63.3B in revenue over the trailing twelve months, up 1.4% year over year.
- Is Pfizer profitable?
- Pfizer reported $12.1B in net income over the trailing twelve months, a 15.7% net margin.
- What is Pfizer's earnings per share?
- Pfizer's diluted EPS over the trailing twelve months is $2.12.
- Where does Pfizer's income statement data come from?
- Every line is extracted from Pfizer's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
